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Immune cell-specific transcriptional 
profiling highlights distinct 
molecular pathways controlled 
by Tob1 upon experimental 
autoimmune encephalomyelitis
Alessandro Didonna, Egle Cekanaviciute, Jorge R. Oksenberg & Sergio E. Baranzini
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system characterized by 
focal lymphocytic infiltration, demyelination and neurodegeneration. Despite the recent advances in 
understanding MS molecular basis, no reliable biomarkers have been identified yet to monitor disease 
progression. Our group has previously reported that low levels of TOB1 in CD4+ T cells are strongly 
associated with a higher risk of MS conversion in individuals experiencing an initial demyelinating 
event. Consistently, Tob1 ablation in mice exacerbates the clinical phenotype of the MS model 
experimental autoimmune encephalomyelitis (EAE). To shed light on Tob1 molecular functions in 
the immune system, we have conducted the first cell-based transcriptomic analysis in Tob1−/− and 
wildtype mice upon EAE. Next-generation sequencing was employed to characterize the changes in 
gene expression in T and B cells at pre- and post-symptomatic EAE stages. Remarkably, we found only 
modest overlap among the different genetic signatures, suggesting that Tob1 may control distinct 
genetic programs in the different cytotypes. This hypothesis was corroborated by gene ontology 
and global interactome analyses, which highlighted specific cellular pathways in each cellular subset 
before and after EAE induction. In summary, our work pinpoints a multifaceted activity of Tob1 in both 
homeostasis and disease progression.
Transducer of ERBB.2-1 (Tob1) belongs to the evolutionary conserved Tob/BTG protein family of genes, which 
includes six members in vertebrates1. All proteins from this family exert their anti-proliferative functions through 
a common N-terminal domain that also regulates their translocation between the cytosolic and nuclear com-
partments2. Tob1 is ubiquitously expressed at different developmental stages, where it participates in a variety 
of biological processes3,4. Moreover, Tob1 plays a central role in the immune system to maintain cell quiescence. 
Specifically, it has been shown to be highly expressed in unstimulated peripheral blood T lymphocytes and under-
going down-regulation during activation5.
From a molecular standpoint, Tob1 inhibits cell proliferation at different levels. Tob1 forms a complex with 
Smad proteins and blocks transcription of mitogenic genes such as cytokines and cyclins by binding to their pro-
moter regions5,6. In addition to a direct control of transcription, Tob1 also inhibits the expression of mitogenic 
genes at the level of translation by preventing circularization of the messenger RNA (mRNA) and hence entry into 
the ribosomal 60S subunit at the 5′ end of the mRNA target7. Finally, Tob1 affects mRNA stability by promoting 
its decay through deadenylation of the poly (A) tail6.
We have recently identified Tob1 as a robust biomarker for multiple sclerosis (MS) progression. MS is an auto-
immune disease of the central nervous system (CNS) characterized by focal lymphocytic infiltration, microglial 
activation, demyelination and axonal degeneration8. MS initial manifestation consists in an isolated demyelinat-
ing event referred as clinically isolated syndrome (CIS). However, not all individuals with CIS develop a clini-
cally definite form of MS9. We found that low levels of Tob1 mRNA in CD4+ T cells of CIS patients are strongly 
correlated with a higher risk of early conversion to MS10. Subsequent studies employing Tob1-knockout mice 
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confirmed that the absence of Tob1 in the experimental autoimmune encephalomyelitis (EAE) paradigm was 
associated with increased inflammation, infiltrating T cells and myelin-reactive Th1 and Th17 cells11.
Given the physiological role of Tob1 in modulating gene expression at multiple levels, here we further dissect 
its contribution to autoimmune demyelination by analyzing the molecular pathways controlled by Tob1 in the 
immune system upon EAE induction. We demonstrate that cell-specific next-generation RNA sequencing is a 
reliable approach to gain insight into the functional role of Tob1 in the principal immune cytotypes. For the first 
time, we show that distinct molecular pathways are activated by Tob1 in different cell populations, suggesting a 
multifaceted activity of Tob1 in both homeostasis and disease progression.
Results
Microarray analysis of gene expression in splenocytes from Tob1−/− mice. In order to investigate 
the transcriptional role of Tob1 in the immune system, we studied the effects of Tob1 absence on the transcrip-
tome of splenocytes upon EAE, a murine model that recapitulates several features of MS12. Mononuclear cells 
(MNCs) were isolated from the spleens of Tob1−/− mice and Tob1+/+ littermates at baseline and at day 15 after 
EAE induction (15 dpi), corresponding to the peak of the disease11. Total RNA was purified from each cell sample 
and subjected to microarray hybridization as described in the Material and Methods section. To better isolate 
the molecular events genuinely driven by Tob1 ablation, we decided to focus our investigation to cross-genotype 
comparisons at the selected time points. Differential expression analysis between Tob1−/− and Tob1+/+ (wild 
type) genotypes identified 106 significant genes at baseline and 113 genes at 15 dpi with P < 0.01 (Supplementary 
Table S1). Minimal overlap exists between the two sets of transcriptional signatures. Indeed, only Tob1 itself and 
chromodomain helicase DNA binding protein 7 (Chd7) were differentially expressed before and after EAE induc-
tion. Interestingly, Tob1 levels were increased in knockout mice. This apparent paradox is explained by the fact 
that the disruption of Tob1 open reading frame does not prevent its transcription but only the translation process, 
as confirmed by Western blot (Supplementary Fig. S1). We then performed gene ontology (GO) analysis on the 
differentially expressed genes to look for possible enrichment in GO categories functionally connected with Tob1 
activities. No significant enrichment of specific biological processes was found at any of the two selected time 
points. The presence of multiple cell types in our samples most likely accounts for the negative results of pathway 
analysis. Thus, we proceeded to a cell-based approach in order to minimize the confounding effects of cellular 
heterogeneity.
RNA-seq on immune cell subpopulations. Tob1 is a well-established inhibitor of either CD4+ or CD8+ T 
cell proliferation5,11. However, no evidence exists for an analogous role of Tob1 on B cell proliferative phenotype. 
For this reason, splenocytes were isolated from Tob1−/− mice and wild type littermates and were stimulated in 
vitro with lipopolysaccharide (LPS). After 3 days, proliferation of B cells was analyzed by FACS using B220 as a 
marker. Remarkably, Tob1-knockout B cells showed a statistically significant increase in cell division compared 
to wild type cells either before (one-tailed T-test, P = 0.013) or after stimulation (one-tailed T-test, P = 0.017) 
(Fig. 1a,b). Furthermore, we tested whether Tob1 deficiency affected the secretion of key cytokines and immu-
noglobulins (Ig). Untouched B cells isolated by negative selection with a purity > 90% (Supplementary Fig. S2) 
Figure 1. Tob1 ablation increases B cell proliferative capacity. WT or Tob1-KO splenocytes were stimulated 
with 5 μ g/mL lipopolysaccharides (LPS) for 3 days or left unstimulated. Afterwards, cells were fixed and the B 
cell population immunostained with a PE-conjugated anti-B220. Cell proliferation analysis was then performed 
by flow cytometry as described in the Materials and Methods section. Tob1-KO B cells show a statistically 
significant increase in cell proliferation either (a) before stimulation or (b) after stimulation as compared to WT 
cells. Results are shown as mean ± SE and derive from three independent experiments, each one using 3 mice 
per genotype. * * P ≤ 0.01, one-tailed T test.
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were used for this set of experiments. In details, the concentrations of Il-6 and Il-10 as well as IgG and IgM were 
measured in the conditioned media from unstimulated and LPS-stimulated B cells. No differences were found 
between knockout and wild type cells for all the tested factors (Fig. 2a–d.) However, a negative trend was detected 
for IgG levels in Tob1-knockout B cells with borderline significance (two-tailed T-test, P = 0.068) (Fig. 2c). Thus, 
we decided to include also the B lineage in the panel of cell subpopulations to test in our transcriptomic analysis.
CD4+ T cell, CD8+ T cell and B cells were immunopurified by magnetic bead technology from the spleens of 
Tob1−/− mice and wild type littermates. The purity of the different populations (at least 95%) was further con-
firmed by qRT-PCR, analyzing the levels of CD4, CD8 and B220 transcripts in each cell subset (Supplementary 
Fig. S3). In addition to the disease peak (15 dpi), we extended our analysis to include a pre-symptomatic stage 
(5 dpi) to better characterize EAE progression. So each cytotype was longitudinally represented by 3 genetic 
profiles, for a total of 18 datasets between the two mouse genotypes. This time, RNA-seq was employed as 
sequencing method instead of microarrays.
In order to decouple the global effects of Tob1 deficiency and EAE progression on the different cell popu-
lations, the genes expressed in all the experimental conditions with the highest variance (SD > 150 across all 
the datasets) were selected from each profile and subjected to principal component analysis (PCA) (Fig. 3a). 
Principal components 1 and 2 clearly segregated the samples into two distinct clusters –corresponding to the B 
and T cell lineages– but the contributions of genotype and disease progression were not clearly discriminated. In 
order to further explore sample aggregation by their expression profiles, we performed unsupervised hierarchical 
clustering (Fig. 3b). Consistent with the PCA results, the heatmap shows that samples segregate first by cytotype, 
forming three big clusters. However, the effects of EAE induction and Tob1 ablation were different within each 
cell population. For example, the genetic signatures of CD4+ and B cells cluster first by day of disease and then by 
genotype. On the contrary, CD8+ T cell genetic profiles cluster by genotype first. This effect seems to be driven 
at least in part by two genes encoding for ribosomal proteins − 60S acidic ribosomal protein P1 (Rplp1) and 60S 
ribosomal protein L41 (Rpl41) – which were strongly down-regulated in Tob1−/− CD8+ T cells only, irrespectively 
of the disease stage.
Next, we quantified the differences in gene expression between Tob1-knockout and wild type cells for 
every EAE time point investigated. For each cell type, we plotted the fraction of genes that were significantly 
up-regulated or down-regulated in Tob1−/− compared to Tob+/+ cells (Fig. 4). Notably, at baseline both CD4+ and 
CD8+ T cell populations show only down-regulated genes while the vast majority of differentially expressed genes 
in B cells is up-regulated in Tob1−/− mice. This finding might reflect the molecular commonalities between the 
two T cell lineages compared to B cells. Interestingly, after EAE induction the differences between T and B cells 
were strongly mitigated as the ratio between up- and down-regulated genes is closer to 1.
We then checked the degree of overlap of differentially expressed genes among the 3 cell subpopulations. 
Consistently with the results from microarray analysis, almost no overlap exists among significant genes. Thus, 
Figure 2. Cytokine and immunoglobulin profiling in Tob1-KO and WT B cells. B cells were isolated 
by negative selection from the spleens of Tob1 KO or WT mice and then stimulated with 5 μ g/mL 
lipopolysaccharides (LPS) for 3 days or left unstimulated. Conditioned media were subsequently collected and 
probed for the levels of (a) interleukin 6 (Il-6), (b) Il-10, (c) IgG and (d) IgM. No significant differences were 
detected in the secretion of these molecules between WT and KO cells, before or after LPS stimulation. Results 
are shown as mean ± SE and derive from at least 3 animals per genotype.
www.nature.com/scientificreports/
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we extended our analysis to nominally significant genes but very little overlap was again highlighted at the 3 time 
points investigated, confirming that most of the genes regulated by Tob1 are cell-specific (Fig. 5a). Only the mar-
ginal zone B and B1 cell-specific protein (Mzb1) gene was found to be up-regulated in all the 3 Tob1-knockout 
cytotypes at both baseline and 15 dpi. Notably, also within the same cell subpopulation, the number of nominally 
significant genes shared at different time points is minimal (Fig. 5b). Only the radical S-adenosyl methionine 
domain containing 1 (Rsad1) gene was found down-regulated at all the time points in both Tob1-knockout CD4+ 
and CD8+ T cell lineages. In B cells instead, Mzb1 was again found differentially expressed at all the 3 time points. 
In particular, it was up-regulated in knockout B cells at both baseline and 15 dpi, and down-regulated at 5 dpi.
Pathway analysis and protein interaction networks. To understand the biological role of Tob1 
in the different immune cell subsets, we performed gene ontology (GO) analysis on the nominally significant 
genes at each EAE time point (Supplementary Tables S2 and S3). At baseline, the most significant enriched 
category for CD4+ T cells was “homophilic cell adhesion” (fold increase: 11.9, Pcorr = 1.50 × 10−10), mainly 
Figure 3. Clustering analysis of immune cell genetic signatures from Tob1-KO and WT mice upon EAE. 
(a) Plot of the first 2 principal components (PC1 on the x-axis and PC2 on the y-axis) calculated from the 
expression values of the genes with the highest variance that are expressed in CD4+ T cells (in yellow), CD8+ T 
cells (in green) and B cells (in blue) isolated from Tob1-deficient and wildtype mice at different EAE stages (0, 
5 and 15 dpi). Two main clusters can be recognized, corresponding to B and T cell lineages. (b) Unsupervised 
hierarchical clustering of expression values for the same genes and samples as in panel a. Each row represents 
a gene while each column corresponds to a different sample. The distances between genes or samples are 
calculated using Spearman correlation. The different datasets cluster first by cytotype, forming three main 
groups that correspond to CD4+, CD8+ and B cell populations. Within each cluster, the influence of disease 
course prevails on genotype for CD4+ T cells and B cells while the opposite trend is observed for CD8+ T cells.
Figure 4. T and B cells respond differently to Tob1 ablation in terms of differentially expressed genes. 
The number of significant genes that were up- (in blue) or down-regulated (in red) in Tob1-knockout mice 
compared to wildtype animals was plotted for each cell population at the different EAE stages. At baseline, 
CD4+ and CD8+ T cells are characterized by only down-regulated genes while B cells show the opposite 
tendency with most of the significant genes being upregulated. In contrast, at 5 and 15 dpi, the majority of 
significant genes is upregulated for the three cytotypes.
www.nature.com/scientificreports/
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due to the contribution of the protocadherin alpha (Pcdha) and gamma (Pcdhga) clusters which are down-
regulated in Tob1−/− cells. For CD8+ T cells instead, the “cellular molecular catabolic process” category was 
the most enriched at baseline (fold increase: 2.9, Pcorr = 2.20 × 10−3). In particular, several components of the 
ubiquitin-mediated protein degradation pathway (Smurf1, Ubr4, Ubr5, Ube2i, Ube3a, Mid1, Usp24, Usp35, 
Usp9x) were down-regulated in Tob1−/− CD8+ T cells. Notably, Smurf1 encodes for an E3 ligase specific for Smad 
proteins. With regards to B cells, the most significant enrichment was for the category “translation” (fold increase: 
8.3, Pcorr = 12.10 × 10−14) due to the up-regulation of several ribosomal protein (Rpl) genes in Tob1-knockout 
B cells. No significant enrichment was identified at 5 dpi for any cytotype. This observation may be related to 
the fact that even as early as 5 dpi, genes regulated in response to immunization can erase the differences seen 
at baseline. At 15 dpi, significant categories related to immune response were over-represented in CD4+ T cells 
with the most enriched one being “antigen processing and presentation of peptide antigen via MHC class II” (fold 
increase: 44.9, Pcorr = 2.00 × 10−10). “Cell cycle process” was instead the most represented category for CD8+ T 
cells at 15 dpi (fold increase: 3.1, Pcorr = 5.00 × 10−2). Also B cells showed an enrichment in ontologies related to 
cell proliferation with “M phase” as the top category (fold increase: 7.7, Pcorr = 7.90 × 10−9). As expected, several 
genes encoding cyclins and cyclin-dependent kinases (Cdk1, Ccnb2, Ccnf, Cdca3, Cdca8) were upregulated in 
both Tob1-knockout lineages.
Next, we explored Tob1 higher functions by means of a previously validated systems biology approach13,14. We 
used the Cytoscape software to visualize protein interaction networks using each list of differentially expressed 
genes as an input to evaluate the possibility that they act in concert, thus altering key biological pathways. A 
greedy heuristic algorithm was employed to search for all the possible networks from a curated database con-
taining more than 400,000 interactions among 25,000 proteins. All the networks enriched in the input genes 
with a global score (Z-score) higher than 3 were considered significant. A total of 9 networks were identified 
in the analysis (Fig. 6a–c and Supplementary Table S4). With the exception of the B cell lineage, which is repre-
sented only by one network for baseline, both CD4+ and CD8+ T cell populations are described by one network 
at baseline and 5 dpi, and 2 networks at 15 dpi. We then performed GO analysis on each network to look for 
possible emerging functions that were not captured by the seed genes only. The most represented biological 
processes among all the networks were “cell cycle regulation” and “transcription”, and given the known function 
of Tob1 in these processes, this confirms that our approach was able to identify biologically meaningful interac-
tion modules. Remarkably, both networks for CD4+ and CD8+ T cells at 5 dpi –a time point that failed to show 
significantly enriched ontologies in our previous analysis– showed an enrichment in the category “regulation 
of transcription from RNA polymerase II promoter”, further supporting the transcriptional role of Tob1. This 
finding also highlights the higher sensitivity of the systems approach in detecting biologically meaningful rela-
tionships from a large data ensemble. A significant enrichment in “regulation of cell cycle” category connected 
to transcriptional activity and “SMAD binding” terms was also identified in one of the two networks for CD8+ T 
cells at 15 dpi (fold increase: 7.3, Pcorr = 2.50 × 10−18). Also noteworthy, one of the two networks for CD4+ T cells 
at 15 dpi showed “intracellular signaling cascade” (fold increase: 3.90, Pcorr = 5.00 × 10−12) and “protein amino 
Figure 5. Limited overlap exists among CD4+, CD8+ and B cell molecular signatures. (a) Venn diagrams 
showing the overlap among the nominally significant genes (Tob1-KO vs WT) of the three immune cell 
populations at 0, 5 and 15 dpi. (b) Venn diagrams showing the overlap among the nominally significant genes 
identified at the three time points analyzed for each immune cell population. In both cases, the number of genes 
shared by different cytotypes or disease stages is limited.
www.nature.com/scientificreports/
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acid phosphorylation” (fold increase: 5.50, Pcorr = 5.20 × 10−12) as the top categories due to the presence of several 
genes encoding for protein kinases such as Janus kinase 2 (Jak2) and 3 (Jak3), protein kinase C alpha (Prkca) and 
spleen tyrosine kinase (Syk). A comprehensive list of the pathway analysis results for all the networks is presented 
in Supplementary Table S5.
Identification of novel transcripts. Next generation sequencing technology does not rely on 
pre-established probes to quantify gene expression but identifies all the actual RNA molecules in a given sample, 
even those not yet annotated. Thus, we analyzed all the differentially expressed transcripts between wild type and 
Tob1−/− mice that were not associated to an official gene symbol, looking for possible novel genes regulated by 
Tob1. At each time point, several candidates defined only by their genomic positions were identified. After man-
ual inspection, the large majority resulted being composed of Ig genes, pseudogenes and endogenous retroviral 
sequences (SINE and LINE). However, among them we were able to identify a transcript differentially expressed 
in CD4+ T cells at baseline, corresponding to an intergenic long non-coding RNA (lncRNA). According to the 
ENCODE database, this transcript (id: GM3764) maps to mouse chromosome 3 (88,149,275–88,309,108) and 
Figure 6. Global interactome analysis identifies biologically relevant gene networks for each immune cell 
population. (a) Significant networks (Z score > 3) enriched in genes with nominal P values from CD4+ T cell 
comparisons (Tob1-KO vs WT) at different EAE stages. One significant network was identified at 0 and 5 dpi 
while two networks were found at 15 dpi. The analysis was performed using Cytoscape and jActive module 
plugin. (b) Significant networks for CD8+ T cells. Similar to CD4+ T cells, also CD8+ T cells are defined by one 
network at 0 and 5 dpi and two networks at 15 dpi. (c) Significant networks for B cells. Only one network was 
identified at baseline while no network passed the cutoff for the other two EAE time points.
www.nature.com/scientificreports/
7Scientific RepoRts | 6:31603 | DOI: 10.1038/srep31603
exists in different isoforms due to alternative splicing. The isoform that we found differentially expressed in CD4+ 
T cells is the shortest one, composed of two exons out of nine. We further validated this finding by qRT-PCR, 
showing that in Tob1-knockout CD4+ T cells there was > 10 fold increase in the lncRNA levels compared to wild 
type cells (Fig. 7a). A two-fold increase was also highlighted in Tob1-knockout B cells while no difference was 
found in CD8+ T cells.
We then investigated whether increased levels of GM3764 had a measurable effect on cell function. In particu-
lar, given the anti-proliferative role of Tob1, we tested the hypothesis that GM3764 could promote cell division. 
Thus, GM3764 or GFP were overexpressed in mouse 3T3 cells and then cell growth was assessed by XTT assay 
after 48 hours from transfection. We were able to measure a statistically significant 20% increase in proliferation 
(one-tailed T-test; P = 0.019) for cells overexpressing the lncRNA, compared to GFP-expressing control cells 
(Fig. 7b). Notably, we could detect a concomitant 20% increase in phospho-ERK1/2 levels (one-tailed T-test; 
P = 0.005) upon GM3764 overexpression (Fig. 7c). Considering the well-established role of this MAP kinase in 
regulating cell proliferation, the effects of GM3764 on cell growth may, at least in part, be exerted via this molec-
ular pathway.
Discussion
Tob1 is a negative regulator of the immune response with implications in health and disease. However, little 
is known about the genetic networks through which Tob1 exerts its functions. In this work, we used a genetic 
knockout approach and the EAE paradigm to perturb the physiology of the immune system. We then employed 
the latest “omic” tools to identify changes in gene expression induced by Tob1 ablation in resting condition and 
upon disease, at both pre- and post-symptomatic stages. We opted for next-generation sequencing instead of 
microarrays due to better dynamic range of signal quantification as well as the possibility to discover novel 
transcripts15. We show that most of the genes regulated by Tob1 in three main immune cellular subsets –CD4+ 
T cells, CD8+ T cells and B cells– are cell-specific. Indeed, our initial approach of testing differential expression 
in unsorted splenocytes failed to highlight any significant molecular pathway by GO analysis. Our investigation 
was successful only after isolating the three cell sub-populations. Interestingly, we were able to detect enrich-
ment in specific GO categories at baseline and at the EAE peak, but not at 5 dpi. While the significance of this 
finding is unclear, we speculate that in the initial stages of disease the extent of the immune response driven by 
antigen-presentation of MOG peptide was strong enough to overwhelm all the possible differences in terms of 
gene expression due to Tob1 deficiency. Thus, no specific molecular pathway emerged at 5 dpi by comparing 
the genetic signatures of knockout and wild type cells. As EAE progresses, the effects of Tob1 deficiency started 
increasing and tangible differences in specific genetic programs were seen again by day 15 after immunization.
Notably, pathway analysis of genetic profiles at baseline did not show any enrichment in categories directly 
connected to cell proliferation for any of the three cell subsets analyzed. However, we found that the absence of 
Tob1 had an anabolic effect on the physiology of CD8+ T cells and B cells, described by the increase in protein 
translation and the decrease in protein degradation. These cellular processes may still be related to cell cycle as 
they could represent the necessary steps to prepare the cells for mitosis. In CD4+ T cells instead, the only enrich-
ment we found was related to the downregulation of protocadherins in Tob1-knockout mice. These adhesion 
proteins are predominantly expressed in the nervous system where they mediate diverse neurodevelopmental 
processes16. Nevertheless, an immunological function has been recently identified for at least one member in the 
subfamily. Indeed, protocadherin-18 was shown to drive differentiation of CD8+ T cells to the effector memory 
phenotype17. Thus, it should not be excluded that protocadherins might have a role in the CD4+ lineage as well.
Figure 7. The long non-coding RNA GM3764 is dramatically upregulated in Tob1-KO CD4+ T cells and 
promotes cell proliferation. (a) The expression levels for the lncRNA GM3764 were analyzed by quantitative 
RT-PCR in CD4+, CD8+ and B cells at baseline (0 dpi). The data were normalized to GAPDH levels which 
served as internal control. A 16-fold increase in GM3764 expression was detected in Tob1-KO CD4+ T cells 
while a 2-fold increase was identified in KO B cells. No difference was instead reported in CD8+ T cells. 
All experiments were carried out in triplicate and the average values are plotted. (b) GM3764 or GFP were 
overexpressed in 3T3 cells and, after 48 hours, cell growth was assessed by XTT assay. A statistically significant 
increase in cell proliferation was measured in lncRNA-expressing cells compared to control. Results are 
presented as mean ± SE and derive from 4 independent transfections. (c) Phospho-ERK1/2 levels were probed 
in GM3764 overexpressing 3T3 cells for 48 hours. A statistically significant increase in phospho-ERK1/2 levels 
was detected in lncRNA-overexpressing cells compared to control. Endogenous actin levels served as internal 
loading control. Results are presented as mean ± SE and derive from 3 independent transfections. * * P ≤ 0.01, 
one-tailed T test.
www.nature.com/scientificreports/
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Upregulation of genes directly involved in mitosis was seen only at the peak of disease for CD8+ T cells and 
B cells but not for CD4+ T cells, which showed instead an enrichment in genes mediating the immune response. 
However, protein network analysis identified a module for CD4+ T cells at 15 dpi significantly enriched in mem-
bers of the JAK/STAT pathway, a signaling cascade involved in T cell proliferation that is activated by the known 
Tob1 target interleukin-2 (Il2)5,18. Surprisingly, Il2 was not part of the list of nominally significant genes for 
any cell type in our analysis. Nonetheless, a small but consistent increase in Il2 expression was detected in both 
Tob1-knockout T cell lineages at baseline and 15 dpi. The generally low level expression of cytokines, and the 
stringency of our statistical analysis might explain this result.
Importantly, we identified Mzb1 as a novel Tob1 target that was significantly upregulated in knockout animals 
before and after EAE in all the three cell types, despite the minimal overlap in their genetic signatures. Mzb1 
encodes for an endoplasmic reticulum calcium regulator and its low levels were shown to induce the arrest of T 
cell development at pre-TCR selection stage and during positive selection, resulting in peripheral T cell lymphopenia19. 
Moreover, Mzb1 takes also part in the humoral immune response by enabling proper assembly and secre-
tion of mature immunoglobulins20. Hence, Tob1 might control these processes via regulating Mzb1 expression. 
Especially upon an autoimmune attack, Tob1-dependent Mzb1 upregulation might concur to the pathological 
phenotype by inducing the maturation of encephalitogenic T cells as well as by facilitating the production of 
auto-reactive antibodies. In addition, the fact that Mzb1 was found down-regulated in Tob1-knockout B cells at 
5 dpi suggests that this gene might be also subjected –given its important role in antibody maturation– to some 
sort of dynamic control through a negative feedback loop. Such mechanism could be possibly lost as the disease 
evolves and the immune response overwhelms all the cellular checkpoints. For these reasons, Mzb1 could repre-
sent a novel druggable target in the context of autoimmunity that warrants further study.
Our choice of next generation sequencing also allowed us to discover a novel lncRNA which was dramatically 
up-regulated in Tob1−/− CD4+ T cells at baseline. Emerging evidence has revealed that lncRNAs play a key role in 
the regulation of several immunological functions including innate and adaptive immune responses and immune 
cell development21. An increasing number of lncRNAs have been found to be involved in autoimmune diseases as 
well. In the context of MS, the lncRNA Tmevpg1 seems to be the most reliable candidate for its role in controlling 
the persistence of Theiler’s murine encephalomyelitis virus (TMEV) infection, an experimental model of MS22. 
In addition, other lncRNAs controlling CD8+ T cell differentiation and activation may be involved as well23. In 
our case, the pathophysiological role of the identified lncRNA seems to be connected to cell growth stimulation 
as suggested by our in vitro experiments. This is in agreement with our previous work. In fact, low levels of Tob1 
upon disease may promote an aberrant immune response also through GM3764 derepression. Additional exper-
iments in animal models will be required to confirm this preliminary data. Furthermore, the recent evidence that 
this lncRNA is the top enriched candidate in astrocytes24 suggests that might have a role in the nervous system 
as well.
In conclusion, we have shown for the first time that Tob1 drives distinct genetic programs in different immune 
cell populations, although its effects on cell proliferation are phenotypically similar. More importantly, consid-
ering the role of Tob1 in disease progression, the pathways and genes that we have highlighted in this study may 
represent promising targets to develop novel therapeutic approaches for MS.
Materials and Methods
Mouse strains. Tob1−/− mice on a C57BL/6 background were obtained from the RIKEN Bioresource Center. 
These mice are derived from a line produced and maintained by T. Yamamoto (University of Tokyo, Tokyo, 
Japan)25. Genotyping was performed as previously described26. C57BL/6 mice were purchased from The Jackson 
Laboratory. Tob1−/− and wild type littermates (Tob1+/+, C57BL/6) were obtained from a heterozygous breeding 
of Tob1+/− mice. All animal procedures were performed in compliance with experimental guidelines approved by 
the University of California, San Francisco committee on animal research (CAR).
Cell lines. NIH 3T3 cells were obtained from ATCC and maintained in Dulbecco’s Modified Eagle’s medium 
(GIBCO/Invitrogen) supplemented with 10% v/v fetal bovine serum (GIBCO/Invitrogen) and antibiotics 
(100 IU/ml penicillin and 100 mg/ml streptomycin) at 37 °C in a humidified atmosphere with 5% CO2.
EAE induction. 8 week old Tob1−/− mice and wild type littermates were injected subcutaneously with 100 μ g 
MOG35–55 (EZBiolab), in complete Freund’s adjuvant (DIFCO Laboratories). Mice received 400 ng of pertussis 
toxin intraperitoneally both immediately after immunization and 2 days later. Control mice were injected with 
everything except the MOG peptide. For all experiments animals were observed daily, and clinical signs were 
assessed as follows: 0, no signs; 1, decreased tail tone; 2, mild monoparesis or paraparesis; 3, severe paraparesis; 
4, paraplegia; 5, quadraparesis; and 6, moribund or death. Mice with an EAE score ≥ 3 at 15 dpi were used for 
the experiments. All animal experiments were conducted according to protocols approved by the local animal 
welfare committee.
Microarray analysis. Total RNA was extracted using the RNeasy Mini Kit (Invitrogen) from the spleens of 
Tob1−/− and wild type littermates (3 mice per genotype) both before and 15 days after EAE induction (15 dpi). 
Excess DNA was digested on columns using the RNase-free DNase Set (Qiagen). RNA quality control, labeling 
and hybridization onto GeneChip Mouse Gene 1.0 ST Arrays (Affymetrix) were performed at the core facility of 
the Gladstone Institutes (San Francisco, CA). Microarray data were processed in R using the Bioconductor pack-
age and further statistical analyses were carried out using BRB-array Tools (Biometrics Research Branch, NIH). 
Genes were considered nominally significant if the univariate P-value was less than 0.01. Genes were excluded 
from the analysis if less than 10% of the expression data showed at least 1.2-fold change in either direction from 
gene’s median value. Genes with more than 50% of data missing or filtered out were also excluded.
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Cell isolation and RNA-seq. At established time points after EAE induction (0, 5 and 15 dpi) 5 mice per 
genotype were pooled and their spleens harvested. CD4+ T cells, CD8+ T cells and B cells were isolated from 
single cell suspensions by positive immunomagnetic selection using Dynabeads (Invitrogen), following the man-
ufacturer’s instructions. Total RNA was extracted using the RNeasy Mini Kit (Invitrogen), adding lysis buffer 
directly on the bead-bound cells. DNA was digested on columns using the RNase-free DNase Set (Qiagen). The 
quality and quantity of RNA was checked with the BioAnalyzer 2100 (Agilent) and all samples had a RIN between 
9.1 and 10. Sequencing was performed on an Illumina GAIIx platform with 100-base paired-end reads, follow-
ing the stranded Truseq protocol. Library preparation and all sequencing steps were performed by Expression 
Analysis, Inc (Durham, NC). Data analysis was performed using a pipeline implemented into the web-based 
Galaxy platform27–29. In particular, reads were aligned to the most recent mouse genome reference (mm10) and 
assembled into transcripts using TopHat and Cufflink tools. Cuffdiff was then used to calculate the fragments 
per kilobase of exon per million fragments mapped (FPKM) score relative to each gene and estimate the differ-
entially expressed genes between genotypes at each selected time point. P values of 0.05 or less were considered 
significant. Hierarchical clustering was performed with the MultiExperiment Viewer (MeV) software, using the 
Spearman Rank correlation as distance metric30. Principal component analysis (PCA) was performed using the 
ClustVis web tool31.
Western blot assays. Spleen and brain were dissected and homogenized in 10 volumes of cold lysis buffer 
(Tris-HCl, pH 6.8, 50 mM; SDS 2%; glycerol 10%, protease inhibitors). Homogenates were then clarified by brief 
sonication and spun for 5 min at 16000xg to remove cell debris. Supernatants were collected and total proteins 
were quantified using the Bicinchoninic (BCA) Protein Assay Kit (Pierce). About 20 μ g of total proteins were 
separated on a 10% polyacrylamide gel by SDS-PAGE. Proteins were then transferred to nitrocellulose mem-
branes (Immobilion) at 100 V for 30 min. Membranes were then blocked with 5% milk in Tris buffered saline 
supplemented with 0.05% Tween-20 (TBS-T) for 1 hour at room temperature (RT). After blocking, membranes 
were incubated with a primary antibody specific for TOB1 (Sigma) or actin (Cell Signal Technology) in blocking 
solution (1:1000) overnight at 4 °C. The day after, the membranes were washed 3 times with TBS-T and incubated 
with horseradish peroxidase (HRP)-conjugated anti-rabbit IgG (Cell Signal Technology) in blocking solution 
(1:5000) for 1 hour at RT. After extensive washing, membranes were incubated with Supersignal West Dura rea-
gent (Thermo Scientific) and the chemiluminescent signals were detected using a Molecular Imager ChemiDoc 
XRS System equipped with Quantity One software (Bio-Rad).
Quantitative RT-PCR analysis. For mRNA analysis, 500 ng of total RNA was retro-transcribed into 
cDNA with the SuperScript III First-Strand kit (Invitrogen), and 1 μ l of the total reaction volume was used 
for quantitative RT-PCR. All amplifications were performed on a Mx3005P thermocycler (Stratagene), 
using the Power SYBR Green PCR Master Mix (Applied Biosystem). Gene expression levels were ana-
lyzed using the following primers: CD4 forward, 5′ -TCCTTCCCACTCAACTTTGC-3′ ; CD4 reverse, 
5′ -AAGCGAGACCTGGGGTATCT-3′ ; CD8 forward, 5′ -GCTCAGTCATCAGCAACTCG-3′ ; CD8 reverse, 
5′ -ATCACAGGCGAAGTCCAATC-3′ ; B220 forward, 5′ -CAAAGTGACCCCTTACCTGCT-3′ ; B220 reverse, 
5′ -CTGACATTGGAGGTGTGTGT-3′ ; GM3764 forward, 5′ -AAGCCTCATCCTGACATCCT-3′ ; GM3764 
reverse, 5′-TTGGTCTGTGGTCCAGAAAG-3′ ; GAPDH forward, 5′-CATGGCCTTCCGTGTTCCTA-3′; 
GAPDH reverse, 5′-CCTGCTTCACCACCTTCTTGAT-3′ . Each sample was run in triplicate and the Δ Δ Ct 
method was used for relative quantification, with GAPDH expression levels serving as internal control.
Cell proliferation analysis using FACS. Splenocytes were isolated from the spleens of 8–12 week old Tob1−/− 
mice and wild type littermates. After loading with eFluor-670 proliferation dye (eBioscience #65-0840-85) according 
to the instructions, splenocytes were seeded into 96-well U-bottom plates at the concentration of 106 cells/mL in 
RPMI 1640 supplemented with 2 mM L-glutamine, 1 mM sodium pyruvate, 100 IU/mL penicillin, 100 mg/mL 
streptomycin, 50 μ M 2-mercaptoethanol and 10% fetal bovine serum (FBS) and stimulated with 5 μ g/mL lipopol-
ysaccharides (LPS) from E. Coli 0111:B4 (Sigma) or left unstimulated as a control for 3 days. After stimulation, 
cells were incubated in 10% normal mouse serum (Jackson ImmunoResearch #015-000-120) and 1% anti-mouse 
CD16/CD32 antibody (BD Pharmingen #553141) in flow cytometry staining buffer (0.5% BSA, 2 mM EDTA in 
PBS) to reduce nonspecific binding, labeled with live/dead cell marker (Live/Dead Fixable Aqua Dead Cell Stain 
Kit, Thermo Fisher #L-34957) and immunostained with a PE-conjugated anti-B220 antibody (BD Pharmingen 
#553089) using standard flow cytometry staining techniques. After fixing in 2% paraformaldehyde in PBS, the 
cells were subjected to flow cytometry analysis using LSR II analyzer (BD Biosciences). Flow cytometry data 
were analyzed using FlowJo software by gating for lymphocytes based on forward/side scatter, followed by singlet 
selection and dead cell exclusion, followed by gating for B220-PE expression to select B cell population. All gating 
was based on fluorescence-minus-one controls.
Cytokine and IgG quantification. B cells were isolated from the spleens of 7–9 week old Tob1−/− mice 
and wild type littermates by negative selection, using Dynabeads Mouse CD43 (Untouched B cells) (Invitrogen). 
Purified B cells were then seeded into 24-well plates at the concentration of 0.5 × 106/mL in complete RPMI 1640 
medium and stimulated with 5 μ g/mL LPS or left unstimulated as a control for 3 days. Conditioned media were 
subsequently probed by ELISA for the levels of cytokines IL-6 and IL-10 and immunoglobulins IgG and IgM. The 
Mouse IL-6 and IL-10 ELISA Kits (Millipore) and Mouse IgG and IgM ELISA kits (Abcam) were used according 
to the manufacturers’ instructions.
Pathway analysis. The cellular component, molecular function and biological process ontologies were 
annotated for each set of differentially expressed genes (nominally significant, uncorrected P < 0.05), using the 
DAVID tool32,33. Enriched terms in each gene ontology (GO) category were searched against the whole mouse 
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transcriptome, adopting FAT filters. Benjamini–Hochberg post-hoc test was used for multiple-test correction and 
significance was considered at corrected P values of 0.05 or less.
Global interactome analysis. Protein interaction networks were generated using the Cytoscape software34. 
The lists of nominally significant genes from each pairwise comparison were used as input and the neighbors of 
each node were added from a high-quality curated protein–protein interaction network accessible at the Human 
Protein Reference Database (HPRD; http://www.hprd.org/). Cytoscape plugin jActives modules was then used to 
calculate a global score (Z-score) for all the possible networks that could be generated from each input gene list 
using the following parameters: 1000 for the maximum number of modules, 0.2 for the overlap threshold between 
modules and 2 for the search depth. Networks with Z-scores > 3.0 were considered significant.
DNA constructs. The sequence of the lncRNA GM3764 was amplified from CD4+ T cell cDNA using 
the Phusion High Fidelity PCR kit (New England Biolabs) with the following primers: Forward, 5′ -CCCC 
CCCTCGAGAAGCTTGGTACAGGAACTTCG-3′; Reverse, 5′-CCCCCCTCTAGACACAGTATGC 
AATGTTCTTTATT-3′ . The PCR product was then double-digested with the restriction enzymes XhoI and 
XbaI (New England Biolabs) and cloned into the pcDNA3 vector (13031; Addgene) from which the coding 
sequence of GFP had been previously excised using the same pair of enzymes. Cloning was confirmed by 
Sanger sequencing.
Cell proliferation assays. NIH 3T3 cells were grown in 6-well plates and transfected at 90% confluence 
with pcDNA3 plasmid (expressing GM3764 or GFP) using Lipofectamine LTX (Invitrogen), according to man-
ufacturer’s instructions. After 24 hours, transfected cells were re-seeded into 96-well plates at a concentration of 
5,000 cells/well and let grow for additional 24 hours. The day after, cell proliferation was assessed with the Cell 
Proliferation Kit II (Roche), incubating cells with the XTT labeling mix for 4 hours. Absorbance was subsequently 
read at 492 nm with reference wavelength at 690 nm, using a VersaMax plate reader (Molecular Devices).
ERK activation analysis. NIH 3T3 cells were transfected with pcDNA3 plasmid (expressing GM3764 
or GFP) and after 48 hours were lysed in RIPA buffer supplemented with protease and phosphatase inhibitors 
(Roche). Cell extracts were then clarified by centrifugation at 2,300xg for 5 min. An amount equal to 10–20 μ g of 
total proteins was separated by 10% SDS-PAGE and ERK1/2 activation was assessed by Western blot as previously 
described, using a monoclonal antibody specific for phospho-p44/42 Map Kinase (Thr202/Tyr204) (Cell 
Signaling). Actin levels were used as loading control.
References
1. Matsuda, S., Rouault, J., Magaud, J. & Berthet, C. In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Lett 497, 67–72 
(2001).
2. Kawamura-Tsuzuku, J., Suzuki, T., Yoshida, Y. & Yamamoto, T. Nuclear localization of Tob is important for regulation of its 
antiproliferative activity. Oncogene 23, 6630–6638, doi: 10.1038/sj.onc.1207890 (2004).
3. Xiong, B. et al. Tob1 controls dorsal development of zebrafish embryos by antagonizing maternal beta-catenin transcriptional 
activity. Dev Cell 11, 225–238, doi: 10.1016/j.devcel.2006.06.012 (2006).
4. Yoshida, Y. et al. Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell 103, 1085–1097 (2000).
5. Tzachanis, D. et al. Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nat Immunol 2, 
1174–1182, doi: 10.1038/ni730 (2001).
6. Okochi, K., Suzuki, T., Inoue, J., Matsuda, S. & Yamamoto, T. Interaction of anti-proliferative protein Tob with poly(A)-
binding protein and inducible poly(A)-binding protein: implication of Tob in translational control. Genes Cells 10, 151–163, 
doi: 10.1111/j.1365-2443.2005.00826.x (2005).
7. Mangus, D. A., Evans, M. C. & Jacobson, A. Poly(A)-binding proteins: multifunctional scaffolds for the post-transcriptional control 
of gene expression. Genome Biol 4, 223, doi: 10.1186/gb-2003-4-7-223 (2003).
8. Ciccarelli, O. et al. Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging. Lancet Neurol 13, 807–822, 
doi: 10.1016/S1474-4422(14)70101-2 (2014).
9. Hauser, S. L., Chan, J. R. & Oksenberg, J. R. Multiple sclerosis: Prospects and promise. Ann Neurol 74, 317–327, doi: 10.1002/
ana.24009 (2013).
10. Corvol, J. C. et al. Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial 
neurological event. Proc Natl Acad Sci USA 105, 11839–11844, doi: 10.1073/pnas.0805065105 (2008).
11. Schulze-Topphoff, U. et al. Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity. J Exp Med 
210, 1301–1309, doi: 10.1084/jem.20121611 (2013).
12. Zamvil, S. S. & Steinman, L. Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple 
sclerosis. Neuron 38, 685–688 (2003).
13. Baranzini, S. E. et al. Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet 
18, 2078–2090, doi: 10.1093/hmg/ddp120 (2009).
14. Nickles, D. et al. Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls. Hum Mol Genet 22, 
4194–4205, doi: 10.1093/hmg/ddt267 (2013).
15. Hurd, P. J. & Nelson, C. J. Advantages of next-generation sequencing versus the microarray in epigenetic research. Brief Funct 
Genomic Proteomic 8, 174–183, doi: 10.1093/bfgp/elp013 (2009).
16. Chen, W. V. & Maniatis, T. Clustered protocadherins. Development 140, 3297–3302, doi: 10.1242/dev.090621 (2013).
17. Vazquez-Cintron, E. J. et al. Protocadherin-18 is a novel differentiation marker and an inhibitory signaling receptor for CD8+ 
effector memory T cells. PLos One 7, e36101, doi: 10.1371/journal.pone.0036101 (2012).
18. Malek, T. R. & Castro, I. Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity 33, 153–165, 
doi: 10.1016/j.immuni.2010.08.004 (2010).
19. Belkaya, S. et al. Transgenic expression of microRNA-185 causes a developmental arrest of T cells by targeting multiple genes 
including Mzb1. J Biol Chem 288, 30752–30762, doi: 10.1074/jbc.M113.503532 (2013).
20. van Anken, E. et al. Efficient IgM assembly and secretion require the plasma cell induced endoplasmic reticulum protein pERp1. 
Proc Natl Acad Sci USA 106, 17019–17024, doi: 10.1073/pnas.0903036106 (2009).
21. Wu, G. C. et al. Emerging role of long noncoding RNAs in autoimmune diseases. Autoimmun Rev 14, 798–805, doi: 10.1016/j.
autrev.2015.05.004 (2015).
www.nature.com/scientificreports/
1 1Scientific RepoRts | 6:31603 | DOI: 10.1038/srep31603
22. Vigneau, S., Rohrlich, P. S., Brahic, M. & Bureau, J. F. Tmevpg1, a candidate gene for the control of Theiler’s virus persistence, could 
be implicated in the regulation of gamma interferon. J Virol 77, 5632–5638 (2003).
23. Qureshi, I. A., Mattick, J. S. & Mehler, M. F. Long non-coding RNAs in nervous system function and disease. Brain Res 1338, 20–35, 
doi: 10.1016/j.brainres.2010.03.110 (2010).
24. Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral 
cortex. J Neurosci 34, 11929–11947, doi: 10.1523/JNEUROSCI.1860-14.2014 (2014).
25. Yoshida, Y. et al. Mice lacking a transcriptional corepressor Tob are predisposed to cancer. Genes Dev 17, 1201–1206, doi: 10.1101/
gad.1088003 (2003).
26. Ho, K. J. et al. Tob1 is a constitutively expressed repressor of liver regeneration. J Exp Med 207, 1197–1208, doi: 10.1084/
jem.20092434 (2010).
27. Giardine, B. et al. Galaxy: a platform for interactive large-scale genome analysis. Genome Res 15, 1451–1455, doi: 10.1101/
gr.4086505 (2005).
28. Goecks, J., Nekrutenko, A., Taylor, J. & Galaxy, T. Galaxy: a comprehensive approach for supporting accessible, reproducible, and 
transparent computational research in the life sciences. Genome Biol 11, R86, doi: 10.1186/gb-2010-11-8-r86 (2010).
29. Blankenberg, D. et al. Galaxy: a web-based genome analysis tool for experimentalists. Curr Protoc Mol Biol Chapter 19, Unit 19 10 
11–21, doi: 10.1002/0471142727.mb1910s89 (2010).
30. Saeed, A. I. et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34, 374–378 (2003).
31. Metsalu, T. & Vilo, J. ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and 
heatmap. Nucleic Acids Res 43, W566–570, doi: 10.1093/nar/gkv468 (2015).
32. Huang, D. W. et al. The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally 
analyze large gene lists. Genome Biol 8, R183, doi: 10.1186/gb-2007-8-9-r183 (2007).
33. Huang, D. W. et al. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology 
from large gene lists. Nucleic Acids Res 35, W169–175, doi: 10.1093/nar/gkm415 (2007).
34. Cline, M. S. et al. Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2, 2366–2382, 
doi: 10.1038/nprot.2007.324 (2007).
Acknowledgements
This work was supported by grant R01NS088155 to SEB and by FISM-Fondazione Italiana Sclerosi Multipla 
Senior Research Fellowship Cod. 2014/B/1 to AD.
Author Contributions
S.E.B. and J.R.O. conceived and jointly supervised the project. A.D. and E.C. carried out all the experiments. A.D., 
E.C., S.E.B. and J.R.O. analyzed the data and wrote the paper. All authors read and approved the final manuscript.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Didonna, A. et al. Immune cell-specific transcriptional profiling highlights distinct 
molecular pathways controlled by Tob1 upon experimental autoimmune encephalomyelitis. Sci. Rep. 6, 31603; 
doi: 10.1038/srep31603 (2016).
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
 
© The Author(s) 2016
